Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
1.855
+0.005 (0.27%)
At close: Mar 9, 2026, 4:00 PM EDT
1.870
+0.015 (0.81%)
After-hours: Mar 9, 2026, 4:00 PM EDT
Indaptus Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 4 | 10 | 15 | 12 | 47 | - | |
| Market Cap Growth | -61.75% | -31.58% | 21.38% | -73.92% | - | - | |
| Enterprise Value | -2 | 3 | -1 | -16 | 5 | - | |
| Last Close Price | 1.85 | 23.58 | 49.28 | 40.60 | 159.60 | - | |
| PB Ratio | 0.66 | 2.57 | 1.22 | 0.50 | 1.30 | - | |
| P/TBV Ratio | 0.90 | 2.57 | 1.22 | 0.50 | 1.30 | - | |
| Debt / Equity Ratio | 0.00 | 0.02 | 0.01 | 0.00 | 0.01 | - | |
| Net Debt / Equity Ratio | -1.26 | -1.45 | -1.09 | -1.07 | -1.08 | 6.89 | |
| Net Debt / EBITDA Ratio | 0.37 | 0.37 | 0.81 | 1.77 | 5.04 | 0.46 | |
| Net Debt / FCF Ratio | 0.39 | 0.46 | 0.98 | 2.02 | 3.45 | 0.49 | |
| Quick Ratio | 2.61 | 1.71 | 4.82 | 7.70 | 8.50 | 0.81 | |
| Current Ratio | 2.88 | 1.95 | 5.05 | 7.94 | 8.77 | 0.86 | |
| Return on Equity (ROE) | -317.98% | -187.53% | -84.04% | -47.32% | -43.25% | -241.13% | |
| Return on Assets (ROA) | -131.38% | -86.28% | -47.63% | -27.15% | -22.81% | -78.62% | |
| Return on Capital Employed (ROCE) | -344.10% | -389.50% | -134.80% | -60.50% | -21.50% | 1514.20% | |
| Earnings Yield | -406.61% | -148.48% | -104.31% | -117.58% | -16.51% | - | |
| FCF Yield | -362.28% | -121.81% | -90.66% | -107.36% | -24.18% | - | |
| Buyback Yield / Dilution | -97.19% | -11.36% | -1.68% | -101.98% | -110.35% | -165.43% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.